BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 37250804)

  • 1. Genetically proxied impaired GIPR signaling and risk of 6 cancers.
    Rogers M; Gill D; Ahlqvist E; Robinson T; Mariosa D; Johansson M; Cortez Cardoso Penha R; Dossus L; Gunter MJ; Moreno V; Davey Smith G; Martin RM; Yarmolinsky J
    iScience; 2023 Jun; 26(6):106848. PubMed ID: 37250804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced agonist residence time, internalization rate and signalling of the GIP receptor variant [E354Q] facilitate receptor desensitization and long-term impairment of the GIP system.
    Gabe MBN; van der Velden WJC; Gadgaard S; Smit FX; Hartmann B; Bräuner-Osborne H; Rosenkilde MM
    Basic Clin Pharmacol Toxicol; 2020 Jun; 126 Suppl 6(Suppl 6):122-132. PubMed ID: 31299132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatiotemporal regulation of GIPR signaling impacts glucose homeostasis as revealed in studies of a common GIPR variant.
    Yammine L; Picatoste B; Abdullah N; Leahey RA; Johnson EF; Gómez-Banoy N; Rosselot C; Wen J; Hossain T; Goncalves MD; Lo JC; Garcia-Ocaña A; McGraw TE
    Mol Metab; 2023 Dec; 78():101831. PubMed ID: 37925022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a rare glucose-dependent insulinotropic polypeptide receptor variant in a patient with diabetes.
    Jacobi SF; Khajavi N; Kleinau G; Teumer A; Scheerer P; Homuth G; Völzke H; Wiegand S; Kühnen P; Krude H; Gong M; Raile K; Biebermann H
    Diabetes Obes Metab; 2019 May; 21(5):1168-1176. PubMed ID: 30784161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the
    Bowker N; Hansford R; Burgess S; Foley CN; Auyeung VPW; Erzurumluoglu AM; Stewart ID; Wheeler E; Pietzner M; Gribble F; Reimann F; Bhatnagar P; Coghlan MP; Wareham NJ; Langenberg C
    Diabetes; 2021 Nov; 70(11):2706-2719. PubMed ID: 34426508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function.
    Renner S; Fehlings C; Herbach N; Hofmann A; von Waldthausen DC; Kessler B; Ulrichs K; Chodnevskaja I; Moskalenko V; Amselgruber W; Göke B; Pfeifer A; Wanke R; Wolf E
    Diabetes; 2010 May; 59(5):1228-38. PubMed ID: 20185813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of variants in gastric inhibitory polypeptide receptor gene with impaired glucose homeostasis in obese children and adolescents from Berlin.
    Sauber J; Grothe J; Behm M; Scherag A; Grallert H; Illig T; Hinney A; Hebebrand J; Wiegand S; Grüters A; Krude H; Biebermann H
    Eur J Endocrinol; 2010 Aug; 163(2):259-64. PubMed ID: 20516203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional amino acid substitution in the glucose-dependent insulinotropic polypeptide receptor (GIPR) gene is associated with lower bone mineral density and increased fracture risk.
    Torekov SS; Harsløf T; Rejnmark L; Eiken P; Jensen JB; Herman AP; Hansen T; Pedersen O; Holst JJ; Langdahl BL
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E729-33. PubMed ID: 24446656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.
    Pamir N; Lynn FC; Buchan AM; Ehses J; Hinke SA; Pospisilik JA; Miyawaki K; Yamada Y; Seino Y; McIntosh CH; Pederson RA
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E931-9. PubMed ID: 12540373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of G protein-coupled receptor kinases in glucose-dependent insulinotropic polypeptide receptor signaling.
    Tseng CC; Zhang XY
    Endocrinology; 2000 Mar; 141(3):947-52. PubMed ID: 10698169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-dependent insulinotropic polypeptide confers early phase insulin release to oral glucose in rats: demonstration by a receptor antagonist.
    Lewis JT; Dayanandan B; Habener JF; Kieffer TJ
    Endocrinology; 2000 Oct; 141(10):3710-6. PubMed ID: 11014226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-dependent insulinotropic polypeptide (GIP) receptor antagonists as anti-diabetic agents.
    Gasbjerg LS; Gabe MBN; Hartmann B; Christensen MB; Knop FK; Holst JJ; Rosenkilde MM
    Peptides; 2018 Feb; 100():173-181. PubMed ID: 29412817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies.
    Malavazos AE; Iacobellis G; Dozio E; Basilico S; Di Vincenzo A; Dubini C; Menicanti L; Vianello E; Meregalli C; Ruocco C; Ragni M; Secchi F; Spagnolo P; Castelvecchio S; Morricone L; Buscemi S; Giordano A; Goldberger JJ; Carruba M; Cinti S; Corsi Romanelli MM; Nisoli E
    Eur J Prev Cardiol; 2023 Jun; 30(8):680-693. PubMed ID: 36799940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonism attenuates atherosclerosis severity in APOE*3-Leiden.CETP mice.
    van Eenige R; Ying Z; Tramper N; Wiebing V; Siraj Z; de Boer JF; Lambooij JM; Guigas B; Qu H; Coskun T; Boon MR; Rensen PCN; Kooijman S
    Atherosclerosis; 2023 May; 372():19-31. PubMed ID: 37015151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity.
    Mohammad S; Patel RT; Bruno J; Panhwar MS; Wen J; McGraw TE
    Mol Cell Biol; 2014 Oct; 34(19):3618-29. PubMed ID: 25047836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCF1 links GIPR signaling to the control of beta cell function and survival.
    Campbell JE; Ussher JR; Mulvihill EE; Kolic J; Baggio LL; Cao X; Liu Y; Lamont BJ; Morii T; Streutker CJ; Tamarina N; Philipson LH; Wrana JL; MacDonald PE; Drucker DJ
    Nat Med; 2016 Jan; 22(1):84-90. PubMed ID: 26642437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonists in Rodent Pancreatic Beta Cells and Mice.
    Perry RA; Craig SL; Ng MT; Gault VA; Flatt PR; Irwin N
    Clin Med Insights Endocrinol Diabetes; 2019; 12():1179551419875453. PubMed ID: 31548798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of incretin receptors genetic polymorphisms with type 2 diabetes mellitus in Egyptian patients.
    Shalaby SM; Zidan HE; Shokry A; Saeed J; El-Sokkary RH
    J Gene Med; 2017 Sep; 19(9-10):. PubMed ID: 28744963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
    Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
    Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular biology of the GIP receptor.
    Greenwell AA; Chahade JJ; Ussher JR
    Peptides; 2020 Mar; 125():170228. PubMed ID: 31812593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.